Gianfredi Vincenza, Berti Alessandro, Stefanizzi Pasquale, D'Amico Marilena, De Lorenzo Viola, Moscara Lorenza, Di Lorenzo Antonio, Venerito Vincenzo, Castaldi Silvana
Department of Biomedical Sciences for Health, University of Milan, Via Pascal, 36, 20133 Milan, Italy.
Interdisciplinary Department of Medicine, University of Bari Aldo Moro, Piazza G. Cesare 11, 70121 Bari, Italy.
Vaccines (Basel). 2023 Nov 7;11(11):1697. doi: 10.3390/vaccines11111697.
The risk of unfavourable outcomes for SARS-CoV-2 infection is significant during pregnancy and breastfeeding. Vaccination is a safe and effective measure to lower this risk. This study aims at reviewing the literature concerning the anti-SARS-CoV-2 vaccine's acceptance/hesitancy among pregnant and breastfeeding women attending hospital facilities. A systematic review of literature was carried out. Hospital-based observational studies related to vaccination acceptance, hesitancy, knowledge and attitude among pregnant and breastfeeding women were included. Determinants of acceptance and hesitancy were investigated in detail. Quality assessment was done via the Johann Briggs Institute quality assessment tools. After literature search, 43 studies were included, 30 of which only focused on pregnant women (total sample 25,862 subjects). Sample size ranged from 109 to 7017 people. Acceptance of the SARS-CoV-2 vaccine ranged from 16% to 78.52%; vaccine hesitancy ranged between 91.4% and 24.5%. Fear of adverse events for either the woman, the child, or both, was the main driver for hesitancy. Other determinants of hesitancy included religious concerns, socioeconomic factors, inadequate information regarding the vaccine and lack of trust towards institutions. SARS-CoV-2 vaccine hesitancy in hospitalized pregnant women appears to be significant, and efforts for a more effective communication to these subjects are required.
在怀孕期间和母乳喂养期间,感染新型冠状病毒2(SARS-CoV-2)出现不良后果的风险很大。接种疫苗是降低这种风险的一种安全有效的措施。本研究旨在回顾有关在医院设施就诊的孕妇和哺乳期妇女对SARS-CoV-2疫苗的接受度/犹豫情况的文献。进行了文献的系统综述。纳入了与孕妇和哺乳期妇女的疫苗接种接受度、犹豫情况、知识和态度相关的基于医院的观察性研究。详细调查了接受度和犹豫情况的决定因素。通过约翰·布里格斯研究所质量评估工具进行质量评估。文献检索后,纳入了43项研究,其中30项仅关注孕妇(总样本25862名受试者)。样本量从109人到7017人不等。SARS-CoV-2疫苗的接受度在16%至78.52%之间;疫苗犹豫率在91.4%至24.5%之间。对女性、儿童或两者出现不良事件的恐惧是犹豫的主要驱动因素。犹豫的其他决定因素包括宗教担忧、社会经济因素、关于疫苗的信息不足以及对机构缺乏信任。住院孕妇中对SARS-CoV-2疫苗的犹豫似乎很显著,需要努力与这些人群进行更有效的沟通。